Abstract:Post-translational modifications (PTMs) of proteins increase a biological system's repertoire of regulatory tools to control cellular mechanisms. Protein phosphorylation is the most studied PTM and known to be dysregulated in many diseases, including cancer, and protein kinases are among the most important drug targets. Many proteins across the eukaryotic proteome are phosphorylated, and more than 50,000 unique protein phosphorylation sites have been identified in a single human cell line. Understanding the vast biological networks directed by protein phosphorylation requires deep quantitative mapping of the phosphoproteome across many samples. Multiplexed proteomics using isobaric labeling reagents to barcode proteome samples for simultaneous quantification has greatly increased the throughput of mass spectrometry-based proteomics and enabled the number of analyses required to understand complex biological systems. We are presenting a detailed protocol to use multiplexed proteomics for mapping phosphoproteomes in samples from cell culture experiments and in tissue samples. The protocol includes phosphopeptide enrichment with TiO2 and phosphotyrosine antibody technology. We are using tandem mass tag (TMT) reagents for barcoding the samples allowing parallel quantification of up to 11 samples. The mass spectrometry method is based on the MultiNotch MS3 method to generate quantitative data of high accuracy and reproducibility. Tandem mass spectrometry (MS2) based on regular collision-induced dissociation (CID) and higher-energy collisional dissociation (HCD) is used to maximize the number of quantified phosphopeptides. The protocol typically enables the quantification of more than 20,000 unique phosphoforms (unique patterns of peptide phosphorylations) from proteome samples of human origin requiring less than 8h of mass spectrometry time per sample.

Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways

Quantitative phosphoproteomics by mass spectrometry: past, present, and future

Advances in quantitative high‐throughput phosphoproteomics with sample multiplexing

Quantitative Label-Free Phosphoproteomics Strategy for Multifaceted Experimental Designs

Quantitative phosphoproteomics-based molecular network description for high-resolution kinase-substrate interactome analysis

Large-scale Label-Free Phosphoproteomics: from Technology to Data Interpretation

Phosphoproteomics: a valuable tool for uncovering molecular signaling in cancer cells

Phosphoproteomics Based on Mass Spectrometry (MS): Enrichment, Detection, Assignment and Quantification

Improvement Of The Quantification Accuracy And Throughput For Phosphoproteome Analysis By A Pseudo Triplex Stable Isotope Dimethyl Labeling Approach

Multiplexed quantitative phosphoproteomics of cell line and tissue samples

A Quantitative Chemical Proteomic Strategy for Profiling Phosphoprotein Phosphatases from Yeast to Humans

[Advances in Analysis Techniques of Phosphoproteome].

Targeted proteomics analyses of phosphorylation-dependent signalling networks

Phosphorylated Protein Chip Combined with Artificial Intelligence Tools for Precise Drug Screening

The Divide and Conquer Strategies for Deep Phosphoproteomics Analysis

Detection of Multisite Phosphorylation of Intrinsically Disordered Proteins Using Quantitative Mass-Spectrometry

A Basic Phosphoproteomic-Dia Workflow Integrating Precise Quantification of Phosphosites in Systems Biology

Simultaneous Quantification of Protein Phosphorylation Sites Using Liquid Chromatography-Tandem Mass Spectrometry-Based Targeted Proteomics: a Linear Algebra Approach for Isobaric Phosphopeptides.

Computational analysis of phosphoproteomics: progresses and perspectives.

R2‐P2 rapid‐robotic phosphoproteomics enables multidimensional cell signaling studies

Relative Quantification of Phosphorylated and Glycosylated Peptides from the Same Sample Using Isobaric Chemical Labelling with a Two-Step Enrichment Strategy